Share

Breaking down the barriers to drug development

Dr. Francoise Meunier, EORTC Director General, Sir Michael Rawlins, former chair of NICE, and Robert Strieter, Novartis Institutes for Biomedical Research discuss translational medicine in respiratory disease in Prof. Peter Barnes’ latest instalment of ERS Vision. The film looks at ways to break down the barriers that obstruct and delay the development of new medicines at every stage of the discovery process.

Leading experts in the field tackle issues such as data protection, risk management, protocol development and European regulations, and emphasise the importance of developing active collaborations between the different stakeholders involved in the drug development process.

Back to news list

Related News

  • World Cancer Day: How clinical cancer research changes lives

  • New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events

  • First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG

  • EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology

  • New EORTC quality of life questionnaire for adolescents and young adults with cancer

  • P-Value Workshop

  • EORTC participation at ISPOR Europe 2025 conference

  • EORTC Quality of Life Group participating at the ISOQOL 2025 Conference

  • New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

  • EORTC celebrates the 100th anniversary of p-value on World Statistics Day